Increased cancer risks among arthroplasty patients: 30 year follow-up of the Swedish Knee Arthroplasty Register

European Journal of Cancer

Volumn 47, Issue 7, 2011, Pages 1061-1071

  Wagner, Philippe ^a   Olsson, Håkan ^a   Lidgren, Lars ^a   Robertsson, Otto ^a   Ranstam, Jonas ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer; ET; Knee arthroplasty; MDS; Metal exposure; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RISK; CARCINOGENESIS; DISEASE REGISTRY; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HEMATOPOIESIS; HUMAN; KNEE ARTHROPLASTY; KNEE PROSTHESIS; LATENT PERIOD; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MYELODYSPLASTIC SYNDROME; OSTEOARTHRITIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RHEUMATOID ARTHRITIS; SWEDEN; THROMBOCYTOSIS;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; ARTHROPLASTY, REPLACEMENT, KNEE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; KNEE PROSTHESIS; LEUKEMIA; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; OSTEOARTHRITIS; PROSTATIC NEOPLASMS; REGISTRIES; RISK; SWEDEN; THROMBOCYTHEMIA, ESSENTIAL;

EID: 79952787641     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.11.023     Document Type: Article

References (37)

1. Robertsson O, Lidgren L. Annual report 2008. Available from: http://www.knee.se [accessed 21.07.09].
2. Onega T, Baron J, MacKenzie T. Cancer after total joint arthroplasty: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1532-7. (Pubitemid 44299328)
3. Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. Cancer following hip and knee arthroplasty: record linkage study. Br J Cancer 2005;92:1298-301. (Pubitemid 40604408)
4. Meyskens Jr F. Cancer following total joint arthroplasty. Cancer Epidemiol Biomarkers Prev 2007;16(1):356. (Pubitemid 46383359)
5. Paavolainen P, Pukkala E, Pulkkinen P, Visuri T. Cancer incidence after total knee arthroplasty: a nationwide Finnish cohort from 1980 to 1996 involving 9444 patients. Acta Orthop Scand 1999;70(6):609-17.
6. Lidgren L. Chronic inflammation, joint replacement and malignant lymphoma. J Bone Joint Surg (Br) 2007;90(B):7-10. (Pubitemid 351184783)
7. Visuri T, Pukkala E, Pulkkinen P, Paavolainen P. Decreased cancer risk in patients who have been operated on with total hip and knee arthroplasty for primary osteoarthrosis: a meta-analysis of 6 Nordic cohorts with 73,000 patients. Acta Orthop Scand 2003;74(3):351-60. (Pubitemid 36890745)
8. Olsen JH, Mclaughlin JK, Nyren O, Mellemkjaer L, Lipworth L. Hip and knee implantations among patients with osteoarthritis and risk of cancer: a record-linkage study from Denmark. Int J Cancer 1999;81(1):719-22. (Pubitemid 29214379)
9. Fryzek JP, Ye W, Signorello LB, et al. Incidence of cancer among patients with knee implants in Sweden, 1980-1994. Cancer 2002;94(11):3057-62.
10. Signorello LB, Ye W, Fryzek JP, et al. Nationwide study of cancer risk among hip replacement patients in Sweden. J Nat Cancer Inst 2001;93(18):1405-10. (Pubitemid 32936818)
11. Visuri TI, Pukkala E, Pulkkinen P, Paavolainen P. Cancer incidence and causes of death among total hip replacement patients: a review based on Nordic cohorts with a special emphasis on metal-on-metal bearings. Proc Inst Mech Eng H 2006;220(2):399-407.
12. Lewold S, Olsson H, Gustafson P, Rydholm A, Lidgren L. Overall cancer incidence not increased after prosthetic knee replacement: 14,551 patients followed for 66,622 person-years. Int J Cancer 1996;68(1):30-3.
13. Tharani R, Dorey FJ, Schmalzried TP. The risk of cancer following total hip or knee arthroplasty. J Bone Joint Surg (Am) 2001;83(5):774-80. (Pubitemid 32476106)
14. Nyrén O, McLaughlin JK, Gridley G, et al. Cancer risk after hip replacement with metal implants: a population-based cohort study in Sweden. J Nat Cancer Inst 1995;87(1):28-33.
15. Memoli VA, Urban RM, Alroy J, Galante JO. Malignant neoplasms associated with orthopedic implant materials in rats. J Orthop Res 1986;4:346-55. (Pubitemid 17169609)
16. Gillespie WJ, Frampton CM, Henderson RJ, Ryan PM. The incidence of cancer following total hip replacement. J Bone Joint Surg Br 1988;70:539-42.
17. Visuri T, Koskenvuo M. Cancer risk after McKee-Farrar total hip replacement. Orthopedics 1991;14:137-42.
18. Askling J, Fored CM, Bäcklund E, et al. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 2005;64:1414-20. (Pubitemid 41623850)
19. Bäcklund E, Sundström C, Ekbom A, et al. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 2003;48:1543-50. (Pubitemid 36682361)
20. Bäcklund E, Askling J, Rosenquist R, Ekbom A, Klareskog L. Rheumatoid arthritis and malignant lymphomas. Curr Opin Rheumatol 2004;16:254-61. (Pubitemid 38530494)
21. The National Board of Health and Welfare - Statistical Databases. Available from: http://www.192.137.163.40/epcfs/index.asp?kod=engelska [accessed 21.07.09].
22. National Cancer Register. Available from: http://www.socialstyrelsen.se/ Statistik/statistik-amne/Cancer/index.htm [accessed 21.07.09].
23. Breslow NE, Day NE. Statistical methods in cancer research. The design and analysis of cohort studies. Lyon Int Agency Res Cancer 1980;2:405-6.
24. International Classifications of Diseases. Available from: http://www.who.int/classifications [Accessed 09.05.09].
25. Mabilleau G, Kwon Y, Pandit H, Murray DW, Sakobar A. Metal-on-metal hip resurfacing arthroplasty: a review of periprosthetic biological reactions. Acta Orthop 2008;79(6):734-47.
26. STATA 10, StataCorp. Stata statistical software: release 10. College Station, TX: StataCorp LP; 2007.
27. Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register - a sample survey for year 1998. Acta Oncol 2009;48:127-33.
28. Renehan AG, Tyson M, Matthias E, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78. (Pubitemid 351232031)
29. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, Kitas GD. Obesity in rheumatoid arthritis. Rheumatology (Oxford) 2010 [first published online October 19, 2010].
30. Preston DL, Ron E, Tokuoka S. Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiat res 1994;168:1-64.
31. Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III: leukaemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 1994;137(2):68-97.
32. Waalkes MP, Rehm S. Cadmium and prostate cancer. J Toxicol Environ Health 1994;43:251-69. (Pubitemid 24353634)
33. Guénel P, Imbernon E, Chevalier A, Crinquand-Calastreng A, Goldberg M. Leukaemia in relation to occupational exposures to benzene and other agents: a case-control study nested in a cohort of gas and electric utility workers. Am J Ind Med 2002;42:87-97. (Pubitemid 34822862)
34. Khuder SA, Mutgi AB. Occupational exposure and acute leukaemia. Leuk Res 2005;29:1105-6.
35. West RR, Stafford DA, Farrow A, Jacobs A. Occupational and environmental exposure and myelodysplasia: a case-control study. Leuk Res 1995;19(2):127-39.
36. Ertenli I, Kiraz S, Oztürk MA, et al. Pathologic thrombopoieses of rheumatoid arthritis. Rheumatol Int 2003;23(2):49-60.
37. Andreasson B, Johansson P, Samuelsson J. Essential thrombocytosis. Important to differentiate from reactive/secondary thrombocytosis. Lakartidningen 2009;106(3):110-3 [article in Swedish].